GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Omnicare Inc (FRA:OMN) » Definitions » EV-to-Revenue

Omnicare (FRA:OMN) EV-to-Revenue : 1.79 (As of May. 14, 2024)


View and export this data going back to . Start your Free Trial

What is Omnicare EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Omnicare's enterprise value is €10,114 Mil. Omnicare's Revenue for the trailing twelve months (TTM) ended in Jun. 2015 was €5,646 Mil. Therefore, Omnicare's EV-to-Revenue for today is 1.79.

The historical rank and industry rank for Omnicare's EV-to-Revenue or its related term are showing as below:

FRA:OMN' s EV-to-Revenue Range Over the Past 10 Years
Min: 0   Med: 0   Max: 0
Current: 1.66

FRA:OMN's EV-to-Revenue is not ranked
in the Healthcare Providers & Services industry.
Industry Median: 1.88 vs FRA:OMN: 1.66

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-05-14), Omnicare's stock price is €87.40. Omnicare's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2015 was €53.87. Therefore, Omnicare's PS Ratio for today is 1.62.


Omnicare EV-to-Revenue Historical Data

The historical data trend for Omnicare's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Omnicare EV-to-Revenue Chart

Omnicare Annual Data
Trend Dec05 Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14
EV-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.74 0.86 0.87 1.33 1.42

Omnicare Quarterly Data
Sep10 Dec10 Mar11 Jun11 Sep11 Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15
EV-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.38 1.31 1.42 1.42 1.65

Competitive Comparison of Omnicare's EV-to-Revenue

For the Medical Care Facilities subindustry, Omnicare's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Omnicare's EV-to-Revenue Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Omnicare's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Omnicare's EV-to-Revenue falls into.



Omnicare EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Omnicare's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=10113.884/5646.188
=1.79

Omnicare's current Enterprise Value is €10,114 Mil.
Omnicare's Revenue for the trailing twelve months (TTM) ended in Jun. 2015 adds up the quarterly data reported by the company within the most recent 12 months, which was €5,646 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Omnicare  (FRA:OMN) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Omnicare's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=87.40/53.871
=1.62

Omnicare's share price for today is €87.40.
Omnicare's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2015 adds up the quarterly data reported by the company within the most recent 12 months, which was €53.87.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Omnicare EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Omnicare's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Omnicare (FRA:OMN) Business Description

Traded in Other Exchanges
N/A
Address
Omnicare Inc was formed in 1981 in Delaware. It is a healthcare services company that specializes in the management of complex pharmaceutical care. The Company operates two primary businesses, Long-Term Care Group and Specialty Care Group. Through Long-Term Care Group, the Company provides pharmaceuticals and related pharmacy services to long-term care facilities as well as chronic care facilities and other settings. Through Specialty Care Group, the Company provides specialty pharmacy and commercialization services for the biopharmaceutical industry. The Company's businesses engage in an ongoing program for the development and marketing of new services. The Company serves long-term care institutions and other chronic care settings in approximately 47 states in the U.S. and the District of Columbia. The Company's largest competitor nationally is PharMerica Corporation. It also competes with numerous local and regional institutional pharmacies, pharmacies owned by long-term care facilities and local retail pharmacies. The Company is subject to extensive federal, state and local regulation.